Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Eisai: Pipeline, Products, Performance, Potential | Nov 2009 | £595 | 100% |
| World Pharmaceutical and Biopharmaceutical Market 2010-2015 (Pipeline Analysis of the Top 50 Companies) |
Jul 2010 | £2,845 | 81% |
| Pipeline Insight: Epilepsy Past successes hard to emulate in highly genericized market |
May 2010 | £7,210 | 81% |
| Dementia Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Mar 2011 | £1,265 | 80% |
| Rheumatoid Arthritis Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Oct 2011 | £2,215 | 80% |
| Insomnia Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Dec 2011 | £2,215 | 79% |
| Ovarian Cancer Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Dec 2010 | £1,265 | 79% |
| Endometrial Cancer Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Mar 2011 | £1,265 | 78% |
| Epilepsy Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Dec 2011 | £2,215 | 76% |
| Lennox-Gastaut Syndrome (LGS) Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Nov 2011 | £2,215 | 75% |
| Breast Cancer Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Dec 2010 | £1,265 | 74% |
| Acute Coronary Syndrome (ACS) Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Dec 2011 | £2,215 | 74% |
| Oral Mucositis Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Aug 2011 | £1,265 | 71% |
| Amyotrophic Lateral Sclerosis (ALS) Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Sep 2011 | £2,215 | 69% |
| Therapeutic Monoclonal Antibodies World Market 2011-2021 |
Sep 2011 | £1,699 | 68% |
| Non-Small Cell Lung Cancer (NSCLC) Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Nov 2011 | £2,215 | 67% |
| The Pain Market Outlook to 2016 Healthcare |
Jul 2011 | £2,425 | 66% |
| Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021 |
May 2011 | £1,499 | 66% |
| Migraine Therapeutics Pipeline Assessment and Market Forecasts to 2016 |
Jul 2010 | £1,265 | 66% |
| Small-Molecule Targeted Cancer Therapies: World Market 2011-2021 |
Nov 2011 | £1,699 | 63% |
| Malignant Mesothelioma Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Jul 2011 | £1,265 | 61% |
| Thyroid Cancer Therapeutics Pipeline Assessment and Market Forecast to 2017 |
May 2011 | £1,265 | 60% |
| Osteoporosis & Bone Metabolism Disorders World Market 2010-2025 |
Apr 2010 | £1,499 | 60% |
| Leading Anti-Cancer Drugs World Market Prospects 2011-2021 |
Feb 2011 | £1,499 | 60% |
| Rheumatoid Arthritis: World Drug Market 2011-2021 |
Sep 2011 | £1,699 | 58% |
| The Outlook for Pharmaceuticals in North East Asia | Nov 2011 | £1,995 | 58% |
| Global Image Dermatology Drug Market, 2005-2012, The High-Growth Opportunities in Aesthetic Medicine |
Nov 2005 | £795 | 57% |
| Prospects for Pharma Mergers, Acquisitions and Alliances 2010-2020 |
Jul 2010 | £1,499 | 57% |
| Dermatological Drugs World Market 2011-2026 |
Nov 2010 | £1,499 | 57% |
| Global Pharmaceutical Biotech Market 2010-2025 Market growth, novel technologies and expansion into new therapeutic areas |
Dec 2009 | £1,499 | 56% |
